2017 Diabetes Technology Meeting Agenda

Thursday, November 2, 2017

Workshop A: Reimbursement

Panel 1: Blood Glucose Monitoring, CGM, and Artificial Pancreas

08:00 Moderator

   Craig MacKenzie

   McKinsey & Company, New York, New York

08:05 New Regulatory Policies

   Paul Radensky, MD, JD

   McDermott Will & Emery LLP, Washington, DC

08:20 Impact of Competitive Bidding on CGM

   John Warren

   McDermott+ Consulting, Washington, DC

08:35 CGM Reimbursement

   Allan Glass, MD

   The Endocrine Society, Washington, DC

08:50 Reimbursement Update for CGM and Artificial Pancreas

   Harmeet Chhabra, MA Medtronic, Northridge, California

09:05 Q & A

   09:35 Break

Panel 2: Other Technologies, Pumps, and Mobile Apps

10:00 Moderator Pablo Salazar

   McKinsey & Company, Stamford, Connecticut 10:05 Pumps

   Bruce Quinn, MD, PhD

   Bruce Quinn Associates, Los Angeles, California

10:20 Reimbursement for Digital Health Products

   Robert Guigley, MBA

   Omada Health, Inc., San Francisco, California

10:35 Reimbursement for Digital Health

   Mike Joyce

   McKinsey & Company, Washington, DC

10:50 Legal Aspects of Reimbursement for Telehealth

   Amy Lerman, JD

   Epstein Becker & Green, Washington, DC

11:05 Q & A

11:35  End of workshop/Lunch

Workshop B: Advances in Insulin Delivery

Panel 1: Accurate Insulin Dosing

08:00 Moderators

   Alicia Warnock, MD, FACP

   Walter Reed NMMC, Bethesda, Maryland

   Anant Nigam, MD, FRCP

   Nigam Diabetes Center, Jaipur, India

08:05 Treatment of Uncontrolled Diabetes

   JenniferSherr, MD, PhD

   Yale University, New Haven, Connecticut

08:20 Avoiding Insulin Dose Errors Related to Deficiencies in Decision Support Software

   Andreas Pfutzner, MD, PhD

   PfutznerScience & Health Institute, Mainz, Germany

08:35 Accurate Insulin Dosing for Decision Support

   Ellie Strock, ANP-BC, FAANP, CDE Voluntis, Cambridge, Massachusetts

08:50 PumpDeliveryofU-500Insulin

   Jennal Johnson, MS, FNP, BC-ADM, CDE, CDTC Eli Lilly & Company, Indianapolis, Indiana

   Trang Ly, MBBS, FRACP, PhD

   Insulet Corporation, Billerica, Massachusetts

09:05 Q & A

09:35  Break

Panel 2: Technologies for Insulin/Pen Delivery

10:00 Moderators

   Simon Friedman, PhD

   University of Missouri at Kansas City, Kansas City, Missouri

   Anne Lee, MD, FACE

   Allina Health, Minneapolis, MN

10:05 Clinician’s Perspective on Why We Need Smart Pens

   Bruce Buckingham, MD

   Stanford University, Palo Alto, California

10:20 Whatever Happened to Inhaled Insulin?

   Lutz Heinemann, PhD

   Science & Co., Dusseldorf, Germany

10:35 Advances in Insulin Delivery

   JeffreyJoseph, DO

   ThomasJefferson University, Philadelphia, Pennsylvania

10:50 Update on Oral Insulin Miriam Kidron, PhD

   Oramed Pharmaceutical Inc,Jerusalem, Israel

11:05 Q & A

11:35  End of workshop/Lunch

Workshop C: Social Media for Diabetes – Communications and Advertising

Panel 1: How Social Media Can Promote Healthy Behavior

12:40 Moderators

   Deborah Greenwood, PhD, RN, BC-ADM, CDE, SAADE Mytonomy, Bethesda, Maryland

   Malinda Peeples, MS, RN, CDE, FAADE WellDoc, Baltimore, Maryland

12:45 Role of Mobile Technology in the Management of Diabetes

   Michael Kloss

   Ascensia Diabetes Care, Basel, Switzerland

13:00 Reminders for Engaging with Mobile Applications

   Bijan Najafi, PhD

   Baylor College of Medicine, Houston, Texas

13:15 Gamification for Diabetes to Increase Adherence

   Vishal Khanna, MFA, MPH

   HealthPrize Technologies, Norwalk, Connecticut

13:30 The Quality and Safety of Online Communities

   Elissa R Weitzman, ScD, MSc

   Boston Children’s Hospital | Harvard Medical School, Boston, Massachusetts

13:45 Q & A

14:10  Break

Panel 2: Advertising on Social Media

14:35 Moderator

   Michael Ryan, JD

   McDermott Will & Emery, Washington, DC

14:40 Benefits of Social Media for Diabetes

   David Ahn, MD

   UCLA Health, Valencia, California

14:55 Social Media for Diabetes Communication

   Stayce Beck, PhD, MPH

   U.S. Food and Drug Administration, Silver Spring, Maryland

15:10 Advertising on Social Media

   Michael Bachner

   Novo Nordisk, Inc., PlainsboroTownship, NewJersey

15:25 Legal Issues About Advertising on Social Media

   Michael Ryan, JD

   McDermott Will & Emery, Washington, DC

15:40 Q & A

16:15  End of workshop

16:15–18:30 Poster session first night and inauguration ofthe 2017 Diabetes Technology Meeting

18:30–20:00 Posters remain on display for viewing

Workshop D: Developments in Glucose Monitoring

Panel 1: Technology

12:40 Moderators

   Geoffrey Chase, PhD

   University of Canterbury, Christchurch, Canterbury, New Zealand George Cembrowski, PhD

   Alberta Health Services, Edmonton, Alberta, Canada

12:45 Recent Advanced Diabetes Technologies from Asia

   Koji Sode, PhD

   Tokyo University of Agriculture & Technology, Koganei, Tokyo, Japan

13:00 FDA Policies

   Courtney Lias, PhD

   U.S. Food and Drug Administration, Silver Spring, Maryland

13:15 CGM in Type 2 Diabetes

   Eugene Wright, MD

   Duke University, Fayetteville, North Carolina

13:30 Contact Lenses to Measure Glucose

   Greg Herman, PhD

   Oregon State University, Corvallis, Oregon

13:45 Q & A

14:10  Break

Panel 2: New End Points for Diabetes Technology Clinical Trials

14:35 Moderators

   Judith Fradkin, MD

   NIDDK, National Institutes of Health, Bethesda, Maryland

   Victor Schneider, MD

   NASA Headquarters, Washington, DC

14:40 Glycemic Variability: Multiple Types, Multiple Metrics, and Clinical Utility

   David Rodbard, MD

   Biomedical Informatics Consultants LLC, Potomac, Maryland

14:55 A Non-Traditional Endpoint

   Marc Breton, PhD

   University of Virginia, Charlottesville, Virginia

15:10 A New Definition of Hypoglycemia for Clinical Trials

   Douglas Muchmore, MD Kinexum, La Jolla, California

15:25 New Endpoints and Adaptive Design for Diabetes Clinical Trials

   Alexander Fleming, MD

   Kinexum, Harpers Ferry, West Virginia

15:40 Q & A

16:15  End of workshop

16:15–18:30 Poster session first night and inauguration of the 2017 Diabetes Technology Meeting

18:30– 20:00 posters remain on display for viewing

Friday, November 3, 2017

07:00  Continental Breakfast

Session 1: Artificial Intelligence for Decision Support

08:00 Welcome/Opening Remarks

   David Klonoff, MD, FACP, FRCP (Edin), FellowAIMBE

   Mills-Peninsula Medical Center, San Mateo, California

08:05 How NASA Science and Diabetes Technology Support Each Other

   Jimmy Wu, BS

   Center for Space Medicine, Baylor College of Medicine, Houston, Texas

08:30 Moderators

   Kong Chen, PhD, MSCI

   NIDDK/NIH, Bethesda, Maryland

   Josep Vehi, PhD

   University of Girona, Girona, Spain

08:35 Decision Support Based on Self-Monitoring or Continuous Monitoring Data

   Boris Kovatchev, PhD

   University of Virginia, Charlottesville, Virginia

08:55 Decision Support Systems for Physicians and Patients

   Moshe Phillip, MD

   Schneider Children’s Medical Center of Israel, Petah Tikva, Israel

09:15 Deep Learning to Diagnose Diabetic Retinopathy

   Howard Zisser, MD

   Verily Life Sciences, South San Francisco, California

09:35 Q & A

09:55  Break

Session 2: Privacy for Diabetes Devices

10:20 Diabetes Technology Society Leadership Award

   10:25 Moderator

   Lucia Savage, JD

   Omada Health, San Francisco, California

10:30 Panel Discussion

   Peter Blenkinsop, JD

   Drinker Biddle & Reath LLP, Washington, DC

   Seth Carmody, PhD

   U.S. Food and Drug Administration, Silver Spring, Maryland

   Cora Han, JD

   U.S. Federal Trade Commission, Washington, DC

   W. Nicholson Price II, JD, PhD

   University of Michigan, Ann Arbor, Michigan

   Lucia Savage, JD

   Omada Health, San Francisco, California

   Rachel Seeger, MPA, MA

   U.S. Department of Health and Human Services, Office for Civil Rights, Washington, DC

   Elissa R Weitzman, ScD, MSc

   Boston Children’s Hospital | Harvard Medical School, Boston, Massachusetts

11:35 Q & A

11:55  End of session/Lunch

Session 3: Augmented Reality

12:55 Moderator

   RoyVigneulle, PhD

   U.S. Army Medical Research & Materiel Command MCMR-RTO, Frederick, Maryland

13:00 The Effect ofVirtual Reality on Emotional Reaction to Diabetes-Related Data

   Bryan Gibson, PhD

   University of Utah, Salt Lake City, Utah

13:20 The Underlying Complexity and the Striking Simplicity of Augmented Reality

   Victor Chapela

   Suggestic, San Francisco, California

13:40 Measure and Reduce Stress with VR Biofeedback

   Ben Barone, MA

   Coresights, Washington, DC

14:00 Q & A

14:15  End of session/Break

Session 4: Artificial Pancreas – Recent Innovations in Algorithms

14:40 Moderators

   Guillermo Arreaza-Rubin, MD

   NIDDK, National Institutes of Health, Bethesda, Maryland Boris Kovatchev, PhD

   University of Virginia, Charlottesville, Virginia 14:45 Diabetes Technology Society Artificial Pancreas Award

14:50 Intra Peritoneal AP System

   Katharine Barnard, PhD, CPsychol, AFBPsS

   Bournemouth University / BHR Ltd, Hampshire, United Kingdom

15:00 Pulsatile Insulin Secretion and Subcutaneous Bolusing

   Ananda Basu, MBBS, MD, FRCP (UK) University of Virginia, Charlottesville, Virginia

15:10 The NIH Artificial Pancreas Consortium

   Guillermo Arreaza-Rubin, MD

   NIDDK, National Institutes of Health, Bethesda, Maryland

15:20 The University ofVirginia AP Project

   Stacey Anderson, MD

   University of Virginia, Charlottesville, Virginia

15:30 Performance of the Medtronic 670G

   JenniferSherr, MD, PhD

   Yale University, New Haven, Connecticut

15:40 Performance ofthe Omnipod Personalized Model Predictive Control Algorithm in Type 1 Diabetes

   Trang Ly, MBBS, FRACP, PhD

   Insulet Corporation, Billerica, Massachusetts

15:50 The Bigfoot Automated Insulin Delivery System

   Jen Block, FNP, NP-C, MSN, RN, CDE Bigfoot Biomedical, Inc., Milpitas, California

16:00 Q&A

16:15  End of Session

16:15–18:30 Poster session second night

18:30–20:00 Posters remain on display for viewing

Saturday, November 4, 2017

07:00  ContinentalBreakfast

Session 5: Novel Insulins

08:00 Moderators

   Frank Flacke, PhD

   Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany

   Jeffrey Joseph, DO

   ThomasJefferson University, Philadelphia, Pennsylvania

08:05 Student Award Presentation

08:10 Silver Prize Student Presentation:

   Histological Comparison ofTissue Response for Stainless Steel and Teflon Continuous Subcutaneous Insulin

   Infusion (CSII) Catheters in Live Swine

   David Diaz, PhD

   ThomasJefferson University, Philadelphia, Pennsylvania

08:25 Insulins in the Pipeline

   Eric Zijlstra, PhD Profil, Neuss, Germany

08:40 Intraperitoneal Insulin Delivery

   Frank Doyle, PhD, CPGS

   Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, Massachusetts

08:55 Hepatic-Directed Insulin (Diasome)

   Douglas Muchmore, MD

   Diasome Pharmaceuticals, Cleveland, Ohio

09:10 Update on Biosimilar Insulin

   Lutz Heinemann, PhD

   Science & Co., Dusseldorf, Germany

09:25 SmartInsulin

   Zhen Gu, PhD

   University of North Carolina / North Carolina State University, Chapel Hill, North Carolina

09:40 Q & A

10:00  Break

Session 6: Assessment of Diabetes Technology

10:25 Moderators

   Marc Breton, PhD

   University of Virginia, Charlottesville, Virginia

   Alexander Fleming, MD

   Kinexum, Harpers Ferry, West Virginia

10:30 Meta-Analysis

   John Pickup, MA, BM, DPhil, DSc, FRCPath King’s College London, London, United Kingdom

10:50 Quality of Life

   Katharine Barnard, PhD, CPsychol, AFBPsS

   Bournemouth University / BHR Ltd, Hampshire, United Kingdom

11:10 Cost Efficiency

   Brett McQueen, PhD

   University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado

11:30 Post Market Surveillance

   Alain Silk, PhD

   U.S. Food and Drug Administration, Silver Spring, Maryland

11:50 Q & A

12:05  End of session/Lunch

Session 7: DTS Surveillance Program for Cleared Blood Glucose Monitoring Systems

13:05 Moderators

   Alberto Gutierrez, PhD

   U.S. Food and Drug Administration, Silver Spring, Maryland

   David Klonoff, MD, FACP, FRCP (Edin), FellowAIMBE Mills-Peninsula Medical Center, San Mateo, California

13:10 Results ofthe Surveillance Program

   Michael Kohn, MD, MPP, FACEP

   University of California, San Francisco, San Francisco, California

13:25 Panel Discussion

Session 8: Continuous Insulin Monitoring

13:40 Moderators

   Gerold Grodsky, PhD

   University of California, San Francisco, San Francisco, California

   David Kerr, MD, FRCPE

   William Sansum Diabetes Center, Santa Barbara, California

13:45 The Clinical Need for Insulin Monitoring

   David Kerr, MD, FRCPE

   William Sansum Diabetes Center, Santa Barbara, California

14:00 EIS Spectroscopy for Continuous Insulin Monitoring

   JeffreyT. La Belle, PhD

   Arizona State University, Tempe, Arizona

14:15 Point-of-Care Insulin Monitoring Device for Improved Diabetes Management

   B. Scott Ferguson, PhD

   Aptitude, Santa Barbara, California

14:30 Q & A

14:45  Break

Session 9: Continuous Glucose Monitoring

15:10 Moderator

   John Pickup, BM, BCh, DPhil

   King’s College London School of Medicine, London, UK

15:15 Panel Discussion

   Tim Dunn, PhD

   Abbott Diabetes Care, Alameda, California

   Shinjiro Sekimoto, MS ARKRAY, Inc., Kyoto, Japan

   Peter Simpson, PhD

   Dexcom, San Diego, California

   Robert Vigersky, MD

   Medtronic, Washington, DC

   RobertS. Cargill, PhD

   Pacific DiabetesTechnologies, Portland, Oregon

   Andrew DeHennis, PhD

   Senseonics, Germantown, Maryland

16:15 Q & A

Session 10: Live Demonstration

16:35 Moderators

   John Pickup, BM, BCh, DPhil

   King’s College London School of Medicine, London, UK

   RobertVigersky, MD

   Medtronic, Washington, DC

16:40 Real-Time CGM in Active U.S Soldiers

   Sammy Choi, MD

   Womack Army Medical Center, Fort Bragg, North Carolina

17:00 Adjourn